top of page


23rd Nov 2023
24th Nov 2023
Blue calender_edited.png

Day 1: 23rd November 2023 (Thursday)


9.00 am - 9.30 am​

9.30 am - 11.00 am

10.00 am -  10.30 am

10.30 am - 11.00 am

11.00 am - 11.20 am

11.20 am - 11.30 am

11.30 am - 1.15 pm

11.30 am - 12.00 pm

12.00 pm - 12.20 pm

12.20 pm - 12.40 pm

12.40 pm - 1.00 pm

1.00 pm - 1.15 pm

1.15 pm - 2.00 pm

2.00 pm - 3.10 pm

2.00 pm - 2.20 pm

2.20 pm - 2.40 pm

2.40 pm - 3.10 pm

3.15 pm - 4.00 pm

4.00 pm - 4.30 pm

4.30 pm - 5.15 pm

5.30 pm - 6.30 pm

6.30pm-7.00 pm

7.30 pm onwards

Talk title and speaker name

Registrations + Breakfast, Tea/Coffee

Inauguration Ceremony 

  • Chief Guest: Dr. Rajesh Gokhale, Secretary Department of BioTechnology, Govt of India

  • Guest of Honour: Dr. Hari Pujar, Chief Operating Officer, Tessera Therapeutics

  • Welcome Remarks: Prof. Sudarshan, Deputy Director IIT Bombay

  • Overview of the department: Prof. Mahesh Tirumkudulu, HoD, Chemical Engineering, IIT Bombay

  • Overview of Biopharma Summit: Prof. Pramod Wangikar, Chemical Engineering, IIT Bombay


Talk by the Chief Guest

Dr. Rajesh Gokhale

(Secretary, Department of Biotechnology, Govt of India)


Keynote Speaker

Dr. Hari Pujar (Chief Operating Officer, Tessera Therapeutics)

Tea/Coffee, Snack Break and Networking

Group Photograph for the conference: Outside VMCC

Advanced Bioprocess for production of Biologics Session I (Session Chair: Dr. Debjani Paul)


Keynote Speaker

Talk: Transforming Biopharma: Putting Patients First in a Tech-Driven Hybrid Era - Dr. Mahesh Bhalgat (Chief Operating Officer, Syngene International)


Talk: Modulating glycoform of recombinant antibodies expressed in CHO cells - Dr. Mugdha Gadgil (Principal Scientist, Chemical Engineering and Process Development, CSIR-NCL)

Talk: ‘Media design and feeding strategies based on Metabolomics analysis for improved high cell density fermentation and quality recombinant protein expression for Biopharmaceuticals manufacturing’ - Dr. Sudheerbabu Soorapanini (Assistant Director of Technology, Lupin)

Talk: Emerging Technologies in Biopharmaceuticals and a Roadmap for Translational Research - Dr. Anurag Rathore (Professor, Department of Chemical Engineering, IIT Delhi)

Talk: IITB Research Park 

Lunch Break and Networking

Vaccine (Session Chair: Dr. Prajakta Dandekar)


Talk: Development of novel anti-LLT1 monoclonal antibody ZM008 to enhance NK cell immunoefficacy in solid tumors - Dr. Anurag Tiwari (Zumutor Biologics)


Talk: CHO cell based bioprocess platform for Rapid Development of Protein Subunit Vaccine Candidates against Viral pathogens - Dr. Ravi Mishra (Head Vaccines & Biotherapeutics, CSIR-IMTECH)

Talk: Accelerating Next-Generation Vaccine Development Through Translational Immunology - Dr. Nimesh Gupta (Chief, Vaccine Immunology Laboratory, National Institute of Immunology)


Poster Session

Tea Break

Panel discussion I: Talk to the Doc - Clinician’s Perspective on Biopharma

  • Dr. Nikita Mehra (Associate Professor, Cancer Institute Chennai)

  • Dr. Neena Chitnis (Department of Rheumatology, Lilawati Hospital)

  • Dr. Hasmukh Jain (Professor, Medical Oncology, Tata Memorial Hospital)

  • Dr. Ashish Bakshi (Medical Oncologist, Hiranandani Hospital)

  • Moderator: Dr. Kshitij Jadhav (Assistant Professor, KCDH, IITB)

Keynote Speaker (Session Chair: Dr. Priyanka Singh)

Keynote Talk: AI-ML + Multiplex Libraries for protein, gene & cell therapies - Prof. George Church (Founding core faculty and Lead Synthetic Biology, Wyss Institute, Harvard University)

Poster Session

Special Networking Dinner (3rd Floor, Gulmohar, IIT Bombay Campus)

Blue calender_edited.png

Day 2: 24th November 2023 (Friday)


9.00 am - 9.30 am​

9.30 am - 11.00 am

9.30 am - 9.50 am

9.50 am - 10.10 am

10.10 am - 10.30 am

10.30 am - 10.50 am

11.00 am - 11.30 am

11.30 am - 1.10 pm

11.30 am - 12.10 pm

12.10 pm - 12.30 pm

12.30 pm - 12.50 pm

12.50 pm - 1.10 pm

1.10 pm - 2.00 pm

2.00 pm - 2.30 pm

2.30 pm - 4.00 pm

2.30 pm - 2.50 pm

2.50 pm - 3.10 pm

3.30 pm - 4.00 pm

4.00 pm - 4.30 pm

4.30 pm - 5.15 pm

5.15 pm - 5.45 pm

Talk title and speaker name

Breakfast and Networking

Emerging technologies and AI/ML in Biopharma (Session Chair: Dr. Ashutosh Kumar)


Talk: Bioprocess Development for mAbs and AI/ML in Bioprocess for Next generation Mfg. (Upstream part) - Dr. Sanjeev Gupta (Vice President & Head-Advanced Biotech (Biosimilar), IPCA Laboratories)


Talk: AI/ML in BioPharma R&D: Beyond the Hype - Real-World Case Studies - Dr. Prasad Chodavarapu (Managing Director, Aganitha)

Talk: AI-generated novel Antibody-based therapeutics with pre-defined drug properties - Dr. Ardini Shah (Co-Founder & Chief Executive Officer, immunitoAI)

Talk: Opportunities and Challenges in Developing an End-to-End Continuous Manufacturing Process for Biologics- Dr. Abhishek Mathur (SVP and Head and RnD, Enzene Biosciences Ltd)

Tea/ Coffee, Snack Break and Networking

Advanced Bioprocess and Production of Biologics Session II (Session Chair: Dr. Anu Raghunathan)


Keynote Talk: CMC Progress in Delivering on the Promise of AAV based Gene Therapies - Dr. Ganesh Vedantham (SVP, Technical Development, BioMarin)


Talk: CAR-T cell therapy: "an intent to cure platform technology for cancer - Mr. Shirish Arya (Cofounder & Director of Immunoadoptive Cell Therapy Private Limited (ImmunoACT))

Talk: Development of Biologics for global markets - Key points to consider - Dr. Jyoti Iyer (Scientist and Consultant)

Talk: USP Standards for cell and gene therapy - Dr. Annu Uppal (Director Scientific Affairs, USP)

Lunch Break and Networking

Poster session

Multi-Omics and PAT (Session Chair: Dr. Prakriti Tayalia)

Talk: Upstream Process Intensification - Dr. Ratnesh Jain (Professor, Dept of Chemical Engineering, Institute of Chemical Technology)

Talk: Engineering rCHO cells to increase titers of MABs and vaccine protein sub-units - Insights from omics - Dr. Sarika Mehra  (Professor, Dept of Chemical Engineering, Indian Institute Technology Bombay)

Talk: A biopharma perspective- Recent Developments And The Future - Dr. Praveen Rao (Associate Research Director, Reliance Life Sciences)

Tea break

Panel discussion II: Early Stage Biopharma Investments in India 

  • Mr. Vishesh Rajaram (Managing Partner, Speciale Invest)

  • Ms. Nidhi Mathur (Axilor Labs)

  • Dr. Ashish Ranjan (Vice President, Kotak Private Equity)

  • Mr. Ashish Venkataramani (Partner, Eight Roads Ventures)

  • Ms. Ritu Verma (Co-founder, Managing Partner, Ankur Capital)

  • Moderator: Dr. Abdur Rub (CEO, WRCB, IIT Bombay)

Valedictory Function: Dr. Abdur Rub

Chief Guest: Ms. Poyni Bhat

bottom of page